Wockhardt recalls two drugs; Dalton to make Andes product; French CMO gets cash infusion for expansion;

> India's Wockhardt is recalling small amounts of a couple of drugs because the FDA cited it for not thoroughly investigating customer complaints and getting to the root of the issues. Here and here

> According to a report from CPhI Turkey, manufacturers report that exports to traditional markets were down but exports to South Korea and Russia were up. Release

> Dalton Pharma Services has an agreement to provide Andes Biotechnologies large molecule sterile dose manufacturing services for its Phase I/II clinical trials. Release

> French CMO Indicia Production has received an undisclosed investment from the Amundi Private Equity Funds which it will use for expansion. Release

> Drug manufacturers and suppliers attending CPhI Russia reported that they see the Russian market as a gateway to CIS countries. Release

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.